Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adiana Permanent Birth Control Device Endorsed By FDA Panel In 10-3 Vote

This article was originally published in The Gray Sheet

Executive Summary

Hologic's Adiana permanent female birth control system should be approved by FDA, contingent upon a postmarket study comparing the device with an alternative method of permanent female birth control, the agency's Obstetrics and Gynecology Devices Panel recommended Dec. 13

You may also be interested in...



Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure

Hologic is immediately launching its Adiana permanent female birth control system following receipt of PMA approval, announced July 7

Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure

Hologic is immediately launching its Adiana permanent female birth control system following receipt of PMA approval, announced July 7

Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure

Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.

Related Content

UsernamePublicRestriction

Register

MT025587

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel